Search Results 91-100 of 16951 for monoclonal antibody

  1. Belimumab (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Belimumab injection is used to treat active, autoantibody ... It is a monoclonal antibody that changes the immune system to help control lupus symptoms.

  2. Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery - Mayo Clinic

    Monoclonal antibodies, such as pembrolizumab, may interfere with the ... Prior anti-cancer monoclonal antibody (mAb) =< 4 weeks prior to registration ...

  3. A Study to Evaluate Maximizing Anti-PD-1 Therapy By Monitoring T Cell Responses In Melanoma, Lung and Other Cancer Types - Mayo Clinic

    ... monoclonal antibody, and compare them with clinical outcomes. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...

  4. Testing the Addition of a New Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma - Mayo Clinic

    Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...

  5. Mayo Clinic Proceedings: In the Limelight, May 2021

    ... monoclonal antibody;; The relative lack of awareness by patients and providers of the availability of such therapeutic options; and; The fact that such use of ...

  6. Trastuzumab (intravenous route) - Side effects & uses - Mayo Clinic

    Trastuzumab is a monoclonal antibody. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of normal ...

  7. Rituximab (intravenous route) - Side effects & uses - Mayo Clinic

    Rituximab injection is a monoclonal antibody. Rituximab injection is used together with other medicines (eg, fludarabine cyclophosphamide) to treat chronic ...

  8. Neuromyelitis optica: New therapies offer hope - Mayo Clinic

    The newly approved treatments are three monoclonal antibodies: ... Rituximab, a monoclonal antibody often used to treat NMOSD , costs about $18,000 a year.

  9. Multiple myeloma - Symptoms and causes - Mayo Clinic

    The myeloma cells continue trying to make antibodies, as healthy plasma cells do. But the body can't use these antibodies, called monoclonal proteins or M ...

  10. Mayo Clinic Q&A - Dr. Yi LIn - Multiple myeloma

    We also have since then monoclonal antibody treatments. So, these are again drugs that can be given IV that target certain markers that can show up on plasma ...